Retail Healthcare Sector

Lucid Diagnostics

Market Cap: US$130.4m

Operates as a commercial-stage medical diagnostics technology company in the United States.

Vireo Growth

Market Cap: CA$181.8m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Compugen

Market Cap: US$130.0m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Aldeyra Therapeutics

Market Cap: US$129.4m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Greenwich LifeSciences

Market Cap: US$129.3m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.

InfuSystem Holdings

Market Cap: US$129.0m

Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

Myomo

Market Cap: US$128.4m

A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.

Nektar Therapeutics

Market Cap: US$127.5m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Larimar Therapeutics

Market Cap: US$126.8m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Editas Medicine

Market Cap: US$126.4m

A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.

Scancell Holdings

Market Cap: UK£95.0m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

eXoZymes

Market Cap: US$125.9m

A development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application.

Atossa Therapeutics

Market Cap: US$125.3m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

Jin Medical International

Market Cap: US$124.8m

Engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury.

Seer

Market Cap: US$123.7m

A life sciences company, develops and commercializes products to decode the biology of the proteome.

Nkarta

Market Cap: US$123.5m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Wellgistics Health

Market Cap: US$123.4m

Engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

Protara Therapeutics

Market Cap: US$123.1m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Enanta Pharmaceuticals

Market Cap: US$122.9m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Fate Therapeutics

Market Cap: US$122.7m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

Lyell Immunopharma

Market Cap: US$122.6m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Alector

Market Cap: US$122.0m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

Theratechnologies

Market Cap: CA$167.4m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Vigil Neuroscience

Market Cap: US$116.2m

A clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain in the United States.

American Well

Market Cap: US$115.5m

An enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.

Vaxart

Market Cap: US$115.0m

A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.

ACC Aviation Holdings

Market Cap: US$113.8m

Focuses on developing canna powder products.

Neumora Therapeutics

Market Cap: US$113.5m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

AOTI

Market Cap: UK£85.1m

Produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers worldwide.

InflaRx

Market Cap: US$112.5m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Sangamo Therapeutics

Market Cap: US$111.7m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Orchestra BioMed Holdings

Market Cap: US$111.1m

Operates as a biomedical company.

RAPT Therapeutics

Market Cap: US$110.9m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.

Black Diamond Therapeutics

Market Cap: US$110.9m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

TerrAscend

Market Cap: CA$152.4m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

HLS Therapeutics

Market Cap: CA$151.8m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.